ONCAlert | 2018 ASCO Annual Meeting

Dr. Luke Discusses the Combination of Epacadostat and Pembrolizumab in Melanoma

Jason J. Luke, MD
Published Online: 2:01 PM, Sat September 9, 2017

Jason J. Luke, MD, assistant professor of Medicine, The University of Chicago Medicine, discusses the combination of epacadostat and pembrolizumab (Keytruda) for the treatment of melanoma during the 2017 ESMO Annual Congress.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.